Drug companies, North Dakota argue over state law meant to promote health care access

By: Mary Steurer

Outlets: North Dakota Monitor

Published: March 27, 2026

Words: 1,030

Last Updated: 2 months, 3 weeks ago

Body Text Preview

A federal district court judge is skeptical that low-income North Dakotans actually benefit from a state law intended to safeguard medication discounts.

The 2025 law makes it a class B misdemeanor for drug manufacturers to adopt policies that “deny, restrict, prohibit, or otherwise interfere” with pharmacies’ ability to obtain and dispense discounted prescriptions on behalf of hospitals participating in a federal program known as 340B.

Drug manufacturers sued the state over the law last …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us